Keeson(603610)

Search documents
脑机接口概念股大爆发!麦澜德股价涨超18%、翔宇医疗涨12%,多家上市公司披露最新进展
Sou Hu Cai Jing· 2025-08-12 02:57
8月12日,A股脑机接口概念板块走高,其中截至发稿,麦澜德股价涨超18%,翔宇医疗涨12%,麒盛科技涨10%。另外,创新医疗、诚益通、倍益康等多只 概念股走高。 | | 脑机接口 | | | | --- | --- | --- | --- | | | 1648.57 3.24% | | | | 基金 成分股 | 资金 板块分析 | 新闻 | 简况(F1 | | 人气龙头 | | | | | 1 创新医疗 | 2 际华集团 | | 3 翔宇医疗 | | 9.99% | -3.37% | | 12.05% | | 首板涨停 领涨15次 | 4天2板 领涨5次 | | 领涨5次 | | ●展开分析 | 最新 | 涨幅 + | 流通市值 | | 麦澜德 | 53.01 | 18.46% | 19.5亿 | | ■ 688273 | | | | | 首板涨停 最终涨停 10:14 | | | | | 翔宇医疗 | 65.00 | 12.05% | 104亿 | | 麗 688626 | | | | | 人气龙头3 | | | | | 麒盛科技 | 14.40 | 10.01% | 50.8亿 | | 603610 | ...
脑机接口概念股持续走高,麦澜德20%涨停
Xin Lang Cai Jing· 2025-08-12 02:32
脑机接口概念股持续走高,麦澜德20%涨停,翔宇医疗涨超14%,麒盛科技、创新医疗涨停。 ...
A股脑机接口概念股走强,麒盛科技、创新医疗涨停
Ge Long Hui A P P· 2025-08-12 02:20
Group 1 - The A-share market has seen a strong performance in brain-computer interface concept stocks, with notable increases in share prices for several companies [1] - Major gainers include Mailland, which rose nearly 18%, and Xiangyu Medical, which increased over 10% [1] - Other companies such as Qisheng Technology and Innovation Medical reached their daily limit up of 10%, while Chengyitong and Sanbo Brain Science rose over 8% [1] Group 2 - Detailed stock performance includes: - Mailland (688273) with a 17.99% increase and a market cap of 5.28 billion, year-to-date increase of 129.09% [2] - Xiangyu Medical (688626) with a 10.33% increase and a market cap of 10.2 billion, year-to-date increase of 119.06% [2] - Qisheng Technology (603610) with a 10.01% increase and a market cap of 5.083 billion, year-to-date increase of 15.14% [2] - Innovation Medical (002173) with a 9.99% increase and a market cap of 9.086 billion, year-to-date increase of 158.67% [2] - Chengyitong (300430) with an 8.37% increase and a market cap of 6.329 billion, year-to-date increase of 51.81% [2] - Sanbo Brain Science (301293) with an 8.19% increase and a market cap of 12.8 billion, year-to-date increase of 43.94% [2] - Aipeng Medical (300753) with a 6.54% increase and a market cap of 4.601 billion, year-to-date increase of 107.58% [2] - Weisi Medical (688580) with a 5.91% increase and a market cap of 5.376 billion, year-to-date increase of 104.65% [2] - Lepu Medical (300003) with a 5.61% increase and a market cap of 34.4 billion, year-to-date increase of 62.75% [2]
脑机接口概念异动拉升,麒盛科技直线涨停
Mei Ri Jing Ji Xin Wen· 2025-08-12 02:16
(文章来源:每日经济新闻) 每经AI快讯,脑机接口概念异动拉升,麒盛科技直线涨停,伟思医疗、三博脑科、诚益通、翔宇医 疗、创新医疗等跟涨。 ...
脑机接口板块走高 创新医疗涨停
Xin Lang Cai Jing· 2025-08-12 02:13
Group 1 - The brain-computer interface sector is experiencing a significant rise, with several companies showing strong performance [1] - Innovative Medical has reached its daily limit increase, indicating strong investor interest and confidence [1] - Qi Sheng Technology previously hit its limit up, reflecting positive market sentiment towards the company [1] Group 2 - Companies such as Xiangyu Medical, Mcland, and Beiyikang have all seen their stock prices increase by over 10%, showcasing a broader trend of growth in the sector [1] - Other companies including Aipeng Medical, Chengyitong, Sanbo Brain Science, Weisi Medical, and Lihua Science and Technology are also experiencing upward movement in their stock prices [1]
被麒盛科技 “看重” 的上海舒福德:年年亏损还资不抵债
Zheng Quan Zhi Xing· 2025-08-10 07:44
Core Viewpoint - Qisheng Technology (603610.SH), known as the "first stock of smart beds," is experiencing significant performance fluctuations due to its heavy reliance on overseas markets, which have been pressured by international operating conditions and management issues. The company aims to expand its domestic market presence through the "Shufude" brand, despite challenges in its partnership with Shanghai Shufude, which has faced financial difficulties and operational inefficiencies [3][5][12]. Group 1: Company Performance and Strategy - Qisheng Technology's overseas revenue has been under pressure, leading to substantial fluctuations in its overall performance [3]. - The company plans to leverage the "Shufude" brand to penetrate the domestic smart bed market, which has low market penetration [3][5]. - Despite Shanghai Shufude's poor performance, Qisheng Technology intends to continue supplying products to it, with projected sales increasing to 160 million yuan by 2025 [3][12]. Group 2: Financial Issues and Risks - As of April 2023, Shanghai Shufude is in a state of insolvency, with Qisheng Technology's receivables from it amounting to 112 million yuan, of which 97.16 million yuan is overdue [3][13]. - Shanghai Shufude's financial performance has been disappointing, with revenues of 20.26 million yuan in 2023 and a net loss of 18.96 million yuan [8][10]. - Qisheng Technology has recognized the risk of loss on its receivables from Shanghai Shufude, leading to a provision for bad debts of 87.05 million yuan, impacting its net profit significantly [10][12]. Group 3: Management and Operational Concerns - The partnership with Shanghai Shufude raises concerns due to the lack of relevant experience of its key personnel, particularly Zhao Yunfeng, who has a background primarily in finance [5][7]. - The financing structure for Zhao Yunfeng's investment in Shanghai Shufude involved complex arrangements that raise questions about the financial stability and operational capability of the new entity [5][7]. - Qisheng Technology's decision to grant exclusive distribution rights to a newly established company with insufficient capital and experience has been criticized, especially given the ongoing financial struggles of Shanghai Shufude [8][12].
A股异动丨脑机接口概念拉升,国家医保局支持脑机接口等进入临床并收费
Ge Long Hui A P P· 2025-07-31 07:20
消息面上,为支持药品和医疗器械创新发展,国家医保局制定新上市药品首发价格机制,新增了100多 项与医疗新技术相关的价格项目。神经系统类立项指南统一设立"脑机接口置入费""脑机接口适配费"等 价格项目,脑机接口技术成熟获批进入临床后,可快速进入临床应用并收费。耳鼻喉类立项指南统一设 立"人工耳蜗植入费""发音装置安装费"等价格项目,鼓励医疗机构帮助更多患者"听得见、说得出"。放 射治疗类立项指南统一设立"质子放疗""重离子放疗"等价格项目,促进高端医疗设备的临床转化应用。 与此同时,为鼓励药品研发创新,国家医保局还制定了新上市药品首发价格机制。 格隆汇7月31日|脑机接口概念股拉升,其中,创新医疗逼近涨停,爱朋医疗、三博脑科、熵基科技、 麒盛科技、岩山科技等跟涨。 ...
脑机接口概念拉升,国家医保局支持脑机接口等进入临床并收费!创新医疗逼近涨停,爱朋医疗、三博脑科跟涨
Ge Long Hui· 2025-07-31 07:07
消息面上,为支持药品和医疗器械创新发展,国家医保局制定新上市药品首发价格机制,新增了100多 项与医疗新技术相关的价格项目。神经系统类立项指南统一设立"脑机接口置入费""脑机接口适配费"等 价格项目,脑机接口技术成熟获批进入临床后,可快速进入临床应用并收费。耳鼻喉类立项指南统一设 立"人工耳蜗植入费""发音装置安装费"等价格项目,鼓励医疗机构帮助更多患者"听得见、说得出"。放 射治疗类立项指南统一设立"质子放疗""重离子放疗"等价格项目,促进高端医疗设备的临床转化应用。 与此同时,为鼓励药品研发创新,国家医保局还制定了新上市药品首发价格机制。 格隆汇7月31日|脑机接口概念股拉升,其中,创新医疗逼近涨停,爱朋医疗、三博脑科、熵基科技、 麒盛科技、岩山科技等跟涨。 ...
麒盛科技: 麒盛科技关于完成工商变更登记的公告
Zheng Quan Zhi Xing· 2025-07-23 08:13
Core Viewpoint - The company has completed the registration changes related to its capital, address, and business scope, as approved in its board meeting and annual shareholders' meeting [1]. Group 1: Company Registration Changes - The company has obtained a new business license from the Zhejiang Provincial Market Supervision Administration, reflecting the updated registration details [1]. - The registered capital of the company is now RMB 352.991621 million [1]. - The company is classified as a joint-stock company (listed, natural person investment or control) [1]. Group 2: Business Scope - The company's business scope includes a wide range of activities such as artificial intelligence software development, smart home device manufacturing and sales, motor and control system research and development, and IoT device manufacturing [1]. - The company is also involved in various manufacturing sectors including electronic components, furniture, and home textiles, as well as providing technical services and data processing [1]. - The company has licenses for producing and selling medical devices, as well as engaging in construction engineering design and transportation services [1].
麒盛科技(603610) - 麒盛科技关于完成工商变更登记的公告
2025-07-23 07:45
证券代码:603610 证券简称:麒盛科技 公告编号:2025-039 麒盛科技股份有限公司 关于完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 类型:股份有限公司(上市、自然人投资或控股) 住所:浙江省嘉兴市秀洲区王江泾镇秀水大道 1508 号 法定代表人:唐国海 注册资本:人民币 35,299.1621 万元 成立日期:2005 年 10 月 19 日 麒盛科技股份有限公司(以下简称为"公司")于第三届董事会第二十八次 会议和 2024 年年度股东大会审议通过了《关于变更公司注册资本、注册地址、 经营范围、修订<公司章程>及办理工商变更登记的议案》,具体内容详见公司于 2025 年 4 月 19 日在上海证券交易所网站(www.sse.com.cn)披露的《麒盛科技 关于变更注册资本、注册地址、经营范围及修订<公司章程>并办理工商变更登记 的公告》(公告编号:2025-006)。 近日,公司已完成工商变更登记相关手续,并已取得浙江省市场监督管理局 换发的《营业执照》,具体登记信息如下: 统一社会信用 ...